GRAIL, Inc. (GRAL)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$59.62
-0.91%
Mkt Cap $2.51B
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (12 analysts)
$77.33
Range $54.00 – $130.00
Implied Upside
+29.7%
Consensus $77.33 vs current $59.62
NASDAQ·Healthcare·Medical - Diagnostics & Research
$59.62
-0.91%
Mkt Cap $2.51B
Buy
5
Hold
2
Sell
0
Price Target (12 analysts)
$77.33
Range $54.00 – $130.00
+29.7%
Consensus $77.33 vs current $59.62